ANGES, INC.
- Country
- π―π΅Japan
- Ownership
- Public
- Established
- 1999-12-17
- Employees
- 145
- Market Cap
- -
- Website
- http://www.anges.co.jp
Clinical Trials
11
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)β’ Click on a phase to view related trials
Phase I/II Study of COVID-19 DNA Vaccine (AG0302-COVID19 High-dose)
- Conditions
- COVID-19 Lower Respiratory Infection
- First Posted Date
- 2021-08-06
- Last Posted Date
- 2022-11-09
- Lead Sponsor
- AnGes, Inc.
- Target Recruit Count
- 422
- Registration Number
- NCT04993586
- Locations
- π―π΅
IUHW Narita Hospital, Narita, Chiba, Japan
π―π΅Medical Corporation Heishinkai OCROM Clinic, Suita, Osaka, Japan
π―π΅Medical Corporation Heishinkai ToCROM Clinic, Shinjuku-ku, Tokyo, Japan
Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19)
- Conditions
- COVID-19
- First Posted Date
- 2020-12-07
- Last Posted Date
- 2022-06-08
- Lead Sponsor
- AnGes, Inc.
- Target Recruit Count
- 500
- Registration Number
- NCT04655625
- Locations
- π―π΅
UHW Narita Hospital, Narita, Chiba, Japan
π―π΅Medical Corporation Heishinkai OCROM Clinic, Suita, Osaka, Japan
π―π΅Medical Corporation Tsurukamekai Shinjuku Tsurukame C linic, Shibuya-ku, Tokyo, Japan
Study of COVID-19 DNA Vaccine (AG0302-COVID19)
- Conditions
- COVID-19
- First Posted Date
- 2020-08-26
- Last Posted Date
- 2021-10-04
- Lead Sponsor
- AnGes, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT04527081
- Locations
- π―π΅
Osaka University Hospital, Osaka, Japan
Study of COVID-19 DNA Vaccine (AG0301-COVID19)
- Conditions
- COVID-19
- First Posted Date
- 2020-07-09
- Last Posted Date
- 2021-08-18
- Lead Sponsor
- AnGes, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT04463472
- Locations
- π―π΅
Osaka City University Hospital, Osaka, Japan
AMG0103 in Subjects With Chronic Discogenic Lumbar Back Pain
- First Posted Date
- 2017-08-28
- Last Posted Date
- 2021-10-12
- Lead Sponsor
- AnGes, Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT03263611
- Locations
- πΊπΈ
Keck Medicine of USC, Los Angeles, California, United States
πΊπΈUniversity of California San Diego, San Diego, California, United States
πΊπΈSpine Institute of San Diego, San Diego, California, United States